Immutep MS therapy IMP761 found safe in initial Phase 1 trial data
multiplesclerosisnewstoday.com, discovered 20-Dec at 5:41am
|
-
|
Immutep Announces Initial Safety Data from First-in-Human Phase I Tria...
uk.finance.yahoo.com, discovered 18-Dec at 12:00am
|
-
|
Immutep, Monash Reveal LAG-3 Binding to MHC Class II
miragenews.com, discovered 17-Dec at 3:28pm
|
-
|
Immutep Reveals Promising Data for IMP761 Trial
markets.businessinsider.com, discovered 17-Dec at 9:31am
|
-
|
Immutep and Monash University Announce First Publication Detailing How...
manilatimes.net, discovered 16-Dec at 11:00am
|
-
|
Study Sheds Light on New Ways for Immunotherapy to Better Target Cance...
technologynetworks.com, discovered 16-Dec at 11:00am
|
-
|
Australian research unlocks new path for cancer immunotherapy
news-medical.net, discovered 15-Dec at 1:50pm
|
-
|
Unlocking the potential to better target cancer with immunotherapy
monash.edu, discovered 14-Dec at 11:00am
|
-
|
Immutep shares new cancer study results
ph.investing.com, discovered 13-Dec at 7:43am
|
-
|
Immutep reports positive data in head and neck cancer trial
finnewsnetwork.com.au, discovered 12-Dec at 8:21pm
|
-
|
Immutep Reports Promising New Data In Head And Neck Cancer At ESMO Imm...
menafn.com, discovered 12-Dec at 7:31pm
|
-
|
Immutep’s Promising Trial Results in Cancer Therapy
nasdaq.com, discovered 12-Dec at 9:57am
|
-
|
Immutep begins phase III lung cancer trial
ng.investing.com, discovered 11-Dec at 9:59pm
|
-
|
Immutep launches Phase III trial in lung cancer
sharecafe.com.au, discovered 11-Dec at 4:28am
|
-
|
Immutep Announces Initiation of TACTI-004 Phase III Trial in First Lin...
morningstar.com, discovered 10-Dec at 4:00pm
|
-
|
Is this ASX All Ords stock primed for a takeover offer in 2025?
fool.com.au, discovered 7-Dec at 12:36am
|
-
|
This ASX biotech stock could be the next M&A target
afr.com, discovered 6-Dec at 3:45am
|
-
|
Immutep shares price target raised on study data
investing.com, discovered 15-Nov at 8:12pm
|
-
|
Immutep (NASDAQ:IMMP) Stock, Earnings Estimates, EPS, And Revenue
benzinga.com, discovered 15-Nov at 3:58am
|
-
|
Immutep Limited: Immutep Quarterly Activities Report Q1 FY25
finanznachrichten.de, discovered 30-Oct at 12:06am
|
-
|
Retail therapy: Surprise sales surge
sharecafe.com.au, discovered 1-Oct at 5:51pm
|
-
|
LDC weaves its way to Namoi control
sharecafe.com.au, discovered 1-Oct at 10:00am
|
-
|
CDK 7 Inhibitors Market is Expected to Showcase a Significant Growth b...
prnewswire.co.uk, discovered 26-Sep at 7:30am
|
-
|
Immune Checkpoint Inhibitors Market Surges to USD 168.76 Billion by 20...
prnewswire.co.uk, discovered 26-Sep at 12:09am
|
-
|
Immutep Gets $3.6M R&D Tax Boost from French Gov't
miragenews.com, discovered 25-Sep at 3:44am
|
-
|
Immutep Receives A$3.6 million R&D Tax Incentive from French Governmen...
finance.yahoo.com, discovered 24-Sep at 10:00pm
|
-
|
Immutep recieves R&D tax incentive from France
investing.com, discovered 24-Sep at 9:25pm
|
-
|
Health Check: Experts deliver their verdict on the Healius imaging dea...
stockhead.com.au, discovered 24-Sep at 11:11am
|
-
|
Immutep receives A$3.6 million French R&D Tax Incentive
finnewsnetwork.com.au, discovered 24-Sep at 7:44am
|
-
|
Immutep (ASX:IMM) announces positive results in head and neck cancer t...
finnewsnetwork.com.au, discovered 23-Sep at 5:58am
|
-
|
The 7 biotech stocks (and their trials) these experts are watching rig...
livewiremarkets.com, discovered 20-Sep at 9:54am
|
-
|
$11M Awarded Under ARC's Discovery Indigenous Scheme
miragenews.com, discovered 19-Sep at 9:11pm
|
-
|
Evening Wrap: ASX 200 notches new record on surging mining and energy ...
marketindex.com.au, discovered 19-Sep at 5:41pm
|
-
|
New Data to be Presented from EFTISARC-NEO Phase II Evaluating Novel T...
biospace.com, discovered 18-Sep at 10:00am
|
-
|
Immutep reports positive results in cancer study
ph.investing.com, discovered 18-Sep at 8:57am
|
-
|
Riding high on ESMO data, Nuvalent reaps $500M in offering
bioworld.com, discovered 18-Sep at 4:21am
|
-
|
Immutep’s Efti in Combination with MSD’s KEYTRUDA® Leads to Positive E...
markets.businessinsider.com, discovered 16-Sep at 6:00pm
|
-
|
‘Full steam ahead’: Aussie shares close at record high
aap.com.au, discovered 16-Sep at 5:24pm
|
-
|
Immutep's Efti in Combination with MSD's KEYTRUDA® Leads to Positive E...
tmcnet.com, discovered 16-Sep at 10:00am
|
-
|
Alive and Kicking: Respiri promises breath of life to bottom line afte...
stockhead.com.au, discovered 16-Sep at 10:00am
|
-
|
Immutep joins S&P/ASX indices after quarterly rebalance
ng.investing.com, discovered 11-Sep at 1:18am
|
-
|
Immutep Quarterly Activities Report Q4 FY24
markets.businessinsider.com, discovered 31-Jul at 10:51pm
|
-
|
Clinical trials in cancer and autoimmune diseases: Immutep’s CEO Marc ...
sharecafe.com.au, discovered 30-Jul at 5:52pm
|
-
|
Immutep mulls filings for LAG-3 drug after new readout
pharmaphorum.com, discovered 29-Jul at 10:00am
|
-
|
Potential MS therapy IMP761 to be tested in healthy volunteers
multiplesclerosisnewstoday.com, discovered 25-Jul at 2:59pm
|
-
|
Market Highlights: CrowdStrike plunges 11pc after global outage, as Bi...
couriermail.com.au, discovered 25-Jul at 7:34am
|
-
|
ASX reporting season calendar August 2024
marketindex.com.au, discovered 24-Jul at 4:37pm
|
-
|
Immutep advances with FDA for Phase III lung cancer trial
uk.investing.com, discovered 24-Jul at 12:40am
|
-
|
Immutep Limited: Immutep Announces Successful Meeting with FDA on Phas...
finanznachrichten.de, discovered 22-Jul at 11:30pm
|
-
|
Immutep Announces Successful Meeting With FDA On Phase III Design In N...
menafn.com, discovered 22-Jul at 6:17pm
|
-
|